Lori Anne Kunkel

CIK 1536368 · Acting-Chief Medical Officer · last filed 2026-06-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.59M

Companies

6

Total Filings

48

Lifetime Open-Market Net

-$10.11M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IMRA Director 51,884 $17.02 $883.0K -$345.4K 5 2026-06-09
ORIC Director 84,200 $8.27 $696.3K $0 11 2026-01-06
NRIX Director 0 $16.95 $0 $0 6 2025-05-19
CRIS Director 22,200 $0.42 $9.3K -$15.6K 8 2022-01-31
Forte Biosciences, Inc. (TOCA) Delisted Acting-Chief Medical Officer $0 4 2019-10-04
Loxo Oncology, Inc. (LOXO) Delisted Director 500 -$9.75M 10 2019-02-15

Recent Filings · Page 2 of 5

48 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-07-18 NRIX Gift (G) −54,027 $0 EDGAR
2024-06-14 ORIC Grant (A) $0 EDGAR
2024-06-04 ORIC Exer (M) +20,500 $76.9K EDGAR
2024-05-20 NRIX Grant (A) $0 EDGAR
2024-04-10 IMRA Grant (A) $0 EDGAR
2023-06-15 ORIC Grant (A) $0 EDGAR
2023-05-04 NRIX Grant (A) $0 EDGAR
2022-06-17 ORIC Grant (A) $0 EDGAR
2022-05-06 NRIX Grant (A) $0 EDGAR
2022-01-31 CRIS Grant (A) $0 EDGAR
Showing 1120 of 48
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.